黑料正能量

In collaboration with the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), 黑料正能量 has undertaken an analysis of more than 220 global health partnerships that companies have submitted to the IFPMA’s latest Developing World Health Partnerships Directory. This analysis, together with input from company leaders and a broad cross-section of stakeholders, has culminated in a 黑料正能量 report (to be published later this month) that summarizes the strengths, gaps, and future opportunities for these partnerhips to meet the health needs of low- and middle-income countries.

This webinar will provide a forum for companies and stakeholders to discuss key takeaways from 黑料正能量’s research and to explore some of the questions that remain unanswered.

With speakers from GlaxoSmithKline and Sanofi, we will discuss the rationale for private-sector investment in global health partnerships, lessons learned in developing partnerships for scale and impact, and opportunities for how industry-led partnerships can evolve in the future.

Format

The webinar will involve a teleconference accompanied by a real-time, internet-based presentation using WebEx. Telephone and login instructions will be sent after registration.